Skip to content

Apotheek DK

Active
Public limited companyfounded 1984active for 41 yearsGistelse Steenweg 131, 8200 Brugge, BelgiumKBO/BCE: BE 0426.771.294
Summary

Apotheek DK has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €239,883 and a net result of €49,942. Equity is shrinking by about 4.3% per year across the filed financial years. Its solvency ranks better than 66% of 4,950 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€465,446total assets 2025
Staff
1.8 FTE
Equity
€239,883
Profit
€49,942
Financial health
87 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
GUY SEVRIN · 100%
Accounts 16 days early0 of 6 deeds read
Why 87raises riskSector: Retail trade (NACE 47)Size: 1.8 FTE, total assets €465,446lowers riskFounded in 1984Equity €239,883 (51.5% of total assets)Show the evidence

Checked score

Score 2025
87 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 77-6
equity 51.5% of total assets
Liquidity 35-14
short-term debt 48.3% · cash 7.3%
Profitability 82-18
return on assets 10.7%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,188 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.3%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%▼ -0.2 percentage points vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026highest value 09-2026: 0.3%● unchanged vs 08-2026highest value 10-2026: 0.3%● unchanged vs 09-2026highest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.72, compared with 1.92 in 2024; short-term debt: 48.3% and cash: 7.3% of total assets), and 48.5% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 66% on solvency, 32% on liquidity, 75% on profitability and 77% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1984
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Size: 1.8 FTE, total assets €465,446
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €239,883 (51.5% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €239,883
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
16 days early
2024
28 days early
2023
15 days early
2022
38 days early
2021
38 days early
2020
24 days late
2019
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Equity above €200,000equity €239,883 ▲26.3%
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Controlled by GUY SEVRIN 100% View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View
  • Active since 1984founded 20-12-1984 41 years View

By topic

Financials

Financial year
2025
Total assets
€465,446
Profit
€49,942
Solvency
51.5%
Total assets▲ 41.9%
Net result
20182025
Go to Financials

Timeline

Events
47
Since
1986
Next accounts
by 31-07-2027
  1. 31-12-2024Highest result from 2018 to 2025
  2. 31-12-2024Equity above €150,000
  3. 16-07-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
20-12-1984
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.